Beckley Psytech Limited: Clinical Trials

7 trials sponsored by Beckley Psytech Limited, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 active not recruiting, 1 recruiting, 1 terminated. 4 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 2, Active not recruiting 1, Terminated 1
Phase 24Completed 2, Active not recruiting 1, Recruiting 1

Follow Beckley Psytech Limited: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
BPL-003 Efficacy and Safety in Treatment Resistant Depression
BPL-003 - Treatment Resistant Depression
Phase 2CompletedBeckley Psytech Limited1962023-09-142026-09-10
An Open-Label, Single Dose Study in Patients With Alcohol Use Disorder
BPL-003 - Alcohol Use Disorder
Phase 2CompletedBeckley Psytech Limited132023-05-302026-05-22
An Open-Label Study to Evaluate the Safety, Tolerability and Pharmacodynamics of BPL-003 in Patients With Treatment Resistant Depression
BPL-003 - Treatment Resistant Depression
Phase 2RecruitingBeckley Psytech Limited722023-02-102026-07-06
ELE-101 Safety & Tolerability Study in Healthy Participants and Patients With Depression
ELE-101, ELE-101 Placebo - Healthy Volunteers, Major Depressive Disorder
Phase 1 / Phase 2Active not recruitingEleusis Therapeutics842022-10-272025-02-19
Single Ascending Dose Study With BPL-003 in Healthy Subjects
BPL-003, Placebo - Pharmacokinetics in Healthy Adults
Phase 1CompletedBeckley Psytech Limited622022-02-142024-03-18
Single Ascending Dose Study With 5-MeO-DMT in Healthy Subjects
5-MeO-DMT, Placebo - Pharmacokinetics in Healthy Adults
Phase 1CompletedBeckley Psytech Limited362021-09-222022-10-12
Phase 1b Study in Patients With Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA)
Psilocybin - Short Lasting Unilateral Neuralgiform Headache Attacks
Phase 1TerminatedBeckley Psytech Limited42021-08-112022-10-12

Conditions studied

Depressive Disorder, Treatment-Resistant (2)  ·  Alcoholism (1)  ·  Depression (1)  ·  Depressive Disorder, Major (1)

Interventions

Methoxydimethyltryptamines (1)  ·  Psilocybin (1)

Countries

United Kingdom (7)  ·  Australia (1)  ·  Germany (1)  ·  Poland (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Kevin Craig, M.D. (3)  ·  Neel Bhatt (1)

Results publications

PMID 38616411